|
Dysport™ has been used for years in over 26 countries and will be available in the US in July 2009. It is the first FDA approved drug of its type to compete with BOTOX®, which also uses the botulinum toxin. According to reports, it has been found to take effect within the first day or 2 of treatment. The skin begins smoothing out as treated facial muscles relax. Also, improvements from Dysport™ have been found to last up to 4 months.
According to physician reports, "Both Botox® and Dysport™ temporarily modify the action of facial muscles, smoothing out undesirable lines between the brows, across the forehead or crow's feet to restore a more youthful, less stressed appearance. But they are not interchangeable, they have distinct dosing differences."
Dysport™ is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients under 65 years of age. Basically, it is an injectable used to minimize the appearance of wrinkles and frown lines in the face. It is made using small amounts of abobotulinumtoxinA. Used in very small, controlled amounts, the toxin relaxes the muscles in the face thereby allowing the overlying skin to relax. Dysport™ also has a non-cosmetic version which is used to treat severe muscle spasms in the face and neck.
|